Fine Foods & Pharmaceuticals Ntm

AGM Information • Feb 6, 2025

REQUEST TO SUPPLEMENT THE AGENDA OF THE ORDINARY SHAREHOLDERS' MEETING ON 28 FEBRUARY 2025

Verdellino (Bergamo, Italy), 6 February 2025 - Fine Foods & Pharmaceuticals N.T.M. S.p.A. - an Italian independent Contract Development & Manufacturing Organisation (CDMO) that develops and manufactures contract products for the nutraceutical, pharmaceutical, and cosmetics industries, listed on Euronext STAR Milan (ticker: FF) ("Fine Foods" or the "Company") announces that today it has received a request from the shareholder Eigenfin S.r.l. ("Eigenfin") to integrate the agenda of the Ordinary Shareholders' Meeting scheduled for 28 February 2025 (the "Meeting"), under Art. 126-bis of Legislative Decree no. 58/1998. As a result of this request, the Shareholders' Meeting agenda will be updated to include an item regarding the confirmation of the director appointed by co-optation, under Art. 2386 of the Italian Civil Code.

The explanatory report prepared by Eigenfin, and the relevant documentation concerning the agenda supplement will be made available to the public at Fine Foods' registered office in Zingonia - Verdellino (BG), Via Berlino 39, on the Company's website www.finefoods.it, in the Governance/Meetingssection, and via the ** authorised storage system, managed by Computershare S.p.A. at .

This press release is available in the Investor Relations/Press Releases section of the Company's website www.finefoods.it.

***

*** Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on Borsa Italiana's Euronext STAR Milan (Ticker: FF) is an Italian independent CDMO (Contract Development and Manufacturing Organisation). It develops and manufactures contract products for the nutraceutical, pharmaceutical, and cosmetics industries. Founded in 1984, Fine Foods proved to be a reliable and capable strategic partner for customers in the reference sectors. The company's organisation can provide successful design process and solid, longterm partnerships. The continuous search for excellence is part of the company's business model and includes research and development, innovation, process reliability, product quality, ESG, and sustainable management of the Group's supply chain. Fine Foods is a benefit corporation which relies on certifications and ratings under international standards. These guarantee its sustainability commitment across the business. With €251.8 million revenue in 2023, Fine Foods is a growing and future-oriented company.

***

For further information: Fine Foods & Pharmaceuticals N.T.M. S.p.A. Tel +39 035 4821382 Investor Relations: ir@finefoods.it Media Relations: media.relations@finefoods.it

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia T. +39 035 4821382 info@finefoods.it

CF / P.IVA IT 09320600969 CAP. SOC. € 22.770.445,02

1 / 1